<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00526006</url>
  </required_header>
  <id_info>
    <org_study_id>2006-00673-145</org_study_id>
    <nct_id>NCT00526006</nct_id>
  </id_info>
  <brief_title>PPI-Rebound-Trial. A Study of the Clinical Relevance of the Acid Rebound Phenomena</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zealand University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zealand University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The acid secretion in the stomach seems to increase after withdrawal of min. 8 wks of
      treatment with a PPI (protonpump inhibitor) It is unknown if this acid rebound phenomenon is
      of clinical significance. In a doubleblinded and placebocontrolled study healthy volunteers
      are randomized to treatment with placebo or PPI + placebo. Gastrointestinal symptoms are
      scored once a week and.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2007</start_date>
  <completion_date type="Anticipated">March 2008</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Symptom scores in the reflux part of the GSRS after withdrawal of active treatment in the actively treated group versus the placebo group</measure>
  </primary_outcome>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>esomeprazole</intervention_name>
    <description>40 mg od for 8 wks</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years +

        Exclusion Criteria:

          -  Dyspepsia, heartburn og acid regurgitation within the preceeding 4 weeks

          -  Previous treatment with PPI og H2RA

          -  Previous contact to doctor or hospital because of dyspepsia or reflux

          -  Pregnancy or breast feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christina Reimer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Køge</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christina Reimer, MD</last_name>
    <phone>+45 47 32 29 51</phone>
    <email>rkchre@ra.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Køgw</name>
      <address>
        <city>Koge</city>
        <zip>4600</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Chrístina Reimer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 5, 2007</study_first_submitted>
  <study_first_submitted_qc>September 5, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 6, 2007</study_first_posted>
  <last_update_submitted>September 5, 2007</last_update_submitted>
  <last_update_submitted_qc>September 5, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 6, 2007</last_update_posted>
  <keyword>Clinical significance of the acid rebound phenomenon after withdrawal of treatment with a PPI</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esomeprazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

